Monoclonal antibody research skyrocketed in the 1980s. By the next decade, they hit the market and today, some of the drugs with the highest revenue are
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 789,000 shares, a growth of 6.1% from the November 15th total of 743,700 shares. Currently, 4.6% of the company’s stock are sold short. Based on an […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the sale, the chairman now owns 1,537,543 shares of the company’s stock, […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the completion of the sale, the chairman now owns 1,537,543 shares in the company, […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 8,347 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $5.14, for a total transaction of $42,903.58. Following the completion of the sale, the chairman now owns 1,571,196 shares in the […]